Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Penumbra executive sells over $130k in company stock

Published 04/03/2024, 07:45 PM

In a recent transaction, Johanna Roberts, EVP, Gen. Counsel & Secretary of Penumbra Inc . (NYSE:PEN), sold a total of $130,242 worth of company stock. The sales were conducted on April 1, 2024, and were reported in a filing with the Securities and Exchange Commission dated April 3, 2024.

Roberts sold shares at prices ranging from $216.28 to $223.71, reflecting the weighted average sale prices across multiple trades. The exact number of shares sold at each price within this range was not disclosed in the filing; however, the reporting person has undertaken to provide full information regarding the number of shares and the prices at which the transactions were effected upon request.

The sales were made according to a pre-arranged Rule 10b5-1 trading plan, which allows insiders to sell shares at predetermined times to avoid any accusations of trading on non-public, material information. It's worth noting that a portion of the shares sold by Roberts is subject to vesting conditions.

Following these transactions, Roberts still holds a substantial number of shares in Penumbra Inc., with ownership of 64,282 shares remaining after the sales, as indicated in the SEC filing. Some of these shares are still subject to vesting, which typically means they are tied to the executive's continued service to the company or other performance conditions.

Penumbra Inc., known for its medical devices and surgical instruments, has not released any official statement regarding these transactions at the time of reporting. The company's stock performance and further insider transactions continue to be closely monitored by investors and market analysts.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

InvestingPro Insights

As investors consider the implications of Johanna Roberts' stock sale in Penumbra Inc., a look at the company's financial health and market performance may offer additional context. Penumbra (NYSE:PEN) is currently trading at a high earnings multiple, with a P/E ratio of 90.14 and an adjusted P/E ratio for the last twelve months as of Q4 2023 at 78.66. Despite this high valuation, the company's cash flows can sufficiently cover interest payments, indicating a level of financial stability.

Moreover, Penumbra's liquid assets exceed its short-term obligations, suggesting the company is in a good position to manage its short-term liabilities. This is a vital factor for investors to consider, especially when evaluating the potential risks associated with an executive's decision to sell shares. On the other hand, the company is operating with a moderate level of debt, which may be a strategic approach to leverage growth opportunities while maintaining a manageable debt profile.

From a performance perspective, Penumbra has experienced significant revenue growth, with a 24.95% increase over the last twelve months as of Q4 2023. This growth trajectory is further highlighted by a gross profit margin of 64.49%, which showcases the company's ability to maintain profitability amidst its expansion. It's also worth noting that analysts predict Penumbra will be profitable this year, a sentiment reinforced by the fact that the company has been profitable over the last twelve months.

For those looking to delve deeper into Penumbra's financials and market performance, InvestingPro offers additional insights. There are currently 11 more InvestingPro Tips available at https://www.investing.com/pro/PEN. To access these tips and more detailed analytics, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.